Disruptive mood dysregulation disorder — branching viva

Opening

Examiner: An eight-year-old is in your clinic with severe outbursts three or four times a week and a chronically grouchy, easily annoyed mood at home and school for over a year. His parents want medication and have read he may be bipolar. How do you frame this assessment? [1]

Candidate: I would treat this as a possible disruptive mood dysregulation disorder and a safety concern first. I would take a structured, multi-informant history — child, parents and school — map the picture against the DSM-5-TR criteria, and explicitly exclude a manic or hypomanic episode before discussing any treatment or medication. [1]

Branch 1 — diagnosis

Examiner: What criteria make it DMDD rather than ordinary tantrums or defiance? [1]

Candidate: Severe, recurrent temper outbursts grossly out of proportion and developmentally inconsistent, occurring at least three times a week; a chronic irritable or angry mood most of the day, nearly every day; onset before age ten; duration at least twelve months with no symptom-free stretch over three months; present in two or more settings and severe in at least one; and the child is aged six to eighteen. Both the outbursts and the chronic baseline irritability must be present. [1]

Examiner (probe): Why multi-informant? [2]

Candidate: The cross-setting requirement cannot be established from one source, children and parents each miss part of the picture, and teachers see function and peer behaviour the family does not. School collateral is essential to the diagnosis. [2]

Branch 2 — the bipolar screen

Examiner: Before you label it or prescribe, what must you exclude? [3]

Candidate: A past or current manic or hypomanic episode. I would ask explicitly about any distinct period of elevated, expansive or irritable mood with decreased need for sleep, racing thoughts, grandiosity and goal-directed overactivity. A distinct episodic pattern with decreased need for sleep is bipolar, not DMDD, and it changes the entire management — a stimulant or antidepressant without a mood stabiliser can destabilise it. I would also exclude organic and substance causes. [3]

Branch 3 — differentials and hierarchy rules

Examiner: How do you separate DMDD from ODD and from intermittent explosive disorder? [2]

Candidate: ODD centres on angry or irritable mood plus argumentative, defiant or vindictive behaviour and does not require the severe frequent outbursts; if both DMDD and ODD criteria are met, DSM-5-TR says assign DMDD only. Intermittent explosive disorder is defined by discrete outbursts without the chronic between-outburst baseline irritability, and it is mutually exclusive with DMDD — the chronic baseline tips you to DMDD. [2]

Examiner (probe): And if the irritability is secondary to ADHD, autism or a mood disorder? [2]

Candidate: Then the irritability follows the primary diagnosis and I treat that primary condition by its own guideline. DMDD can be comorbid, but the diagnosis requires the irritability to be the sustained, chronic core, not an episodic or secondary feature. [2]

Branch 4 — treatment

Examiner: What is your first-line plan? [4]

Candidate: Behaviour therapy first: structured parent training such as PCIT, Triple P or Coping Power, plus child emotion-regulation CBT, with a school-based behaviour plan and psychoeducation. The meta-analyses show the most consistent benefit for psychosocial interventions. [4]

Examiner (probe): When is a drug justified? [5]

Candidate: A drug is adjunctive and targets a comorbidity, not the DMDD label. For comorbid ADHD, a stimulant is evidence-supported and tolerated, with close monitoring for mood worsening. For a comorbid depressive or anxiety disorder meeting full criteria, psychotherapy first and fluoxetine if a drug is indicated, always after excluding bipolar. A short-term antipsychotic is reserved for severe dangerous aggression, with specialist input, a defined target and metabolic monitoring. [5]

Branch 5 — the evidence and the corners

Examiner: Her parents have read that a calming tablet is the answer. How do you respond using the evidence? [4]

Candidate: I explain honestly that the strongest and most consistent evidence across interventions is for psychosocial treatments — parent training and CBT — while pharmacological agents show smaller, less consistent effects and carry side-effect burdens. So the plan is built around behaviour therapy, with medication only adjunctive, targeted and time-limited, agreed by shared decision-making with documented goals. [4]

Examiner (final corner): And if the outbursts become dangerous, or she does not respond? [4] [6]

Candidate: Dangerous aggression not safe at home is a behavioural emergency: a safety plan, environmental control, urgent specialist review, and only short-term, targeted pharmacology with a taper. For non-response, I re-check the diagnosis and comorbidity, optimise the behaviour programme, and consider an adapted DBT for children, which the Perepletchikova trial showed was feasible and superior to treatment as usual in preadolescents. I build a relapse-prevention plan with a named coordinator and plan transition to adolescent services in advance. [6]